Found: 23
Select item for more details and to access through your institution.
Second primary ipsilateral breast cancer with contralateral axillary involvement: a case report and literature review.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 202, n. 1, p. 191, doi. 10.1007/s10549-023-07046-3
- By:
- Publication type:
- Article
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 3, p. 597, doi. 10.1007/s10549-022-06621-4
- By:
- Publication type:
- Article
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 641, doi. 10.1007/s10549-021-06292-7
- By:
- Publication type:
- Article
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 411, doi. 10.1007/s10549-021-06329-x
- By:
- Publication type:
- Article
Oncotype DX<sup>®</sup> Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 2, p. 366, doi. 10.1245/s10434-018-07107-8
- By:
- Publication type:
- Article
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00429-7
- By:
- Publication type:
- Article
Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2850
- By:
- Publication type:
- Article
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
- Published in:
- 2011
- By:
- Publication type:
- journal article
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
BRCA1/2 testing: therapeutic implications for breast cancer management.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.
- Published in:
- Breast Journal, 2020, v. 26, n. 8, p. 1506, doi. 10.1111/tbj.13972
- By:
- Publication type:
- Article
How to Manage Patients With Moderate-Risk Germline Mutations.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 2, p. 97
- By:
- Publication type:
- Article
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immediate breast reconstruction following mastectomy in pregnant women with breast cancer.
- Published in:
- Journal of Surgical Oncology, 2016, v. 114, n. 2, p. 140, doi. 10.1002/jso.24308
- By:
- Publication type:
- Article
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 565, doi. 10.1093/oncolo/oyad123
- By:
- Publication type:
- Article
Should We Offer Medication to Reduce Breast Cancer Risk?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 6, p. 901, doi. 10.1002/cncr.34615
- By:
- Publication type:
- Article
Germline genetic testing in breast cancer: Rationale for the testing of all women diagnosed by the age of 60 years and for risk‐based testing of those older than 60 years.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 828, doi. 10.1002/cncr.33305
- By:
- Publication type:
- Article
Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care.
- Published in:
- Journal of Women's Health (15409996), 2022, v. 31, n. 4, p. 495, doi. 10.1089/jwh.2021.0299
- By:
- Publication type:
- Article
Refining Risk Assessment in Women With Benign Breast Disease: An Ongoing Dilemma.
- Published in:
- 2017
- By:
- Publication type:
- journal article